progestin

Wyeth Loses Appeal Over Hormone Replacement Drugs

Wyeth Pharmecuticals on Wednesday lost its appeal of a decision that awarded $58 million in damages to three women who claimed the company's hormone-replacement drugs caused their breast cancer.